ArticleEvaluation of CD4+CD25+ regulatory T cells in patients with hepatocellular carcinoma and liver cirrhosis
ArticleEvaluation of CD4+CD25+ regulatory T cells in patients with hepatocellular carcinoma and liver cirrhosis
ArticleHigh expression of the checkpoint molecule PD-1 on conventional CD4+ and regulatory T cells in the peripheral blood of Hepatocellular carcinoma patients
ArticleHigh expression of the checkpoint molecule PD-1 on conventional CD4+ and regulatory T cells in the peripheral blood of Hepatocellular carcinoma patients
ArticleAssessment of CD4+CD25+ Regulatory T Lymphocytes Cells in Chronic Hepatitis C, Chronic Hepatitis C– Associated Cirrhosis and Hepatocellular Carcinoma Patients
ArticleAssessment of CD4+CD25+ Regulatory T Lymphocytes Cells in Chronic Hepatitis C, Chronic Hepatitis C– Associated Cirrhosis and Hepatocellular Carcinoma Patients
ArticleREGULATION OF CELLULAR IMMUNE RESPONSE BY NATURALLY OCCURRING PRODUCTS ON HEPATOCELLULAR CARCINOMA
ArticleREGULATION OF CELLULAR IMMUNE RESPONSE BY NATURALLY OCCURRING PRODUCTS ON HEPATOCELLULAR CARCINOMA
ArticleHigh expression of the checkpoint molecule PD-1 on conventional CD4+ and regulatory T cells in the peripheral blood of Hepatocellular carcinoma patients
ArticleHigh expression of the checkpoint molecule PD-1 on conventional CD4+ and regulatory T cells in the peripheral blood of Hepatocellular carcinoma patients
ArticleValue of Glypican-3 as a Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma before and after Treatment. A Prospective Study
ArticleValue of Glypican-3 as a Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma before and after Treatment. A Prospective Study